These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2. Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001 [TBL] [Abstract][Full Text] [Related]
4. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. Powell WS; Chung D; Gravel S J Immunol; 1995 Apr; 154(8):4123-32. PubMed ID: 7706749 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils. Ito W; Chiba T; Kanehiro A; Kato H; Yamaguchi K; Ueki S; Kayaba H; Chihara J Allergy; 2007 Apr; 62(4):415-22. PubMed ID: 17362253 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2. Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884 [TBL] [Abstract][Full Text] [Related]
7. The role of platelet-derived growth factor receptor in eotaxin signaling of eosinophils. Adachi T; Hanaka S; Yano T; Yamamura K; Yoshihara H; Nagase H; Chihara J; Ohta K Int Arch Allergy Immunol; 2006; 140 Suppl 1():28-34. PubMed ID: 16772724 [TBL] [Abstract][Full Text] [Related]
8. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils. Royer JF; Schratl P; Carrillo JJ; Jupp R; Barker J; Weyman-Jones C; Beri R; Sargent C; Schmidt JA; Lang-Loidolt D; Heinemann A Eur J Clin Invest; 2008 Sep; 38(9):663-71. PubMed ID: 18837743 [TBL] [Abstract][Full Text] [Related]
9. Stem cell factor stimulates the chemotaxis, integrin upregulation, and survival of human basophils. Heinemann A; Sturm GJ; Ofner M; Sturm EM; Weller C; Peskar BA; Hartnell A J Allergy Clin Immunol; 2005 Oct; 116(4):820-6. PubMed ID: 16210056 [TBL] [Abstract][Full Text] [Related]
10. Leptin has a priming effect on eotaxin-induced human eosinophil chemotaxis. Kato H; Ueki S; Kamada R; Kihara J; Yamauchi Y; Suzuki T; Takeda M; Itoga M; Chihara M; Ito W; Kayaba H; Chihara J Int Arch Allergy Immunol; 2011; 155(4):335-44. PubMed ID: 21346363 [TBL] [Abstract][Full Text] [Related]
11. Bovine eotaxin (CCL11)--an unusual member of the eotaxin group--attracts eosinophils in vitro but is not responsible for eosinophilia in the ovary. Vogel B; Klinder A; Sittig D; Aust G Vet Immunol Immunopathol; 2005 Aug; 107(1-2):67-77. PubMed ID: 15916812 [TBL] [Abstract][Full Text] [Related]
12. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils. Powell WS; Gravel S; Halwani F Am J Respir Cell Mol Biol; 1999 Jan; 20(1):163-70. PubMed ID: 9870930 [TBL] [Abstract][Full Text] [Related]
13. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. Sugimoto H; Shichijo M; Iino T; Manabe Y; Watanabe A; Shimazaki M; Gantner F; Bacon KB J Pharmacol Exp Ther; 2003 Apr; 305(1):347-52. PubMed ID: 12649388 [TBL] [Abstract][Full Text] [Related]
14. Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils. Stubbs VE; Schratl P; Hartnell A; Williams TJ; Peskar BA; Heinemann A; Sabroe I J Biol Chem; 2002 Jul; 277(29):26012-20. PubMed ID: 11980903 [TBL] [Abstract][Full Text] [Related]
15. Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis. Kataoka N; Satoh T; Hirai A; Saeki K; Yokozeki H Immunology; 2013 Sep; 140(1):78-86. PubMed ID: 23582181 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils. Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101 [TBL] [Abstract][Full Text] [Related]
17. Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils. Wong CK; Zhang JP; Ip WK; Lam CW Clin Exp Immunol; 2002 Jun; 128(3):483-9. PubMed ID: 12067303 [TBL] [Abstract][Full Text] [Related]
18. Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4-stimulated epithelial cells. Yuan Q; Campanella GS; Colvin RA; Hamilos DL; Jones KJ; Mathew A; Means TK; Luster AD Eur J Immunol; 2006 Oct; 36(10):2700-14. PubMed ID: 16983721 [TBL] [Abstract][Full Text] [Related]
19. IFN-γ and TNF-α potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor. El-Shazly AE; Moonen V; Mawet M; Begon D; Henket M; Arafa M; Louis R; Delvenne P; Lefebvre PP Int Immunopharmacol; 2011 Nov; 11(11):1864-70. PubMed ID: 21835268 [TBL] [Abstract][Full Text] [Related]
20. The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa. Terada N; Hamano N; Kim WJ; Hirai K; Nakajima T; Yamada H; Kawasaki H; Yamashita T; Kishi H; Nomura T; Numata T; Yoshie O; Konno A Am J Respir Crit Care Med; 2001 Aug; 164(4):575-9. PubMed ID: 11520718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]